BORA and ovarian carcinoma: We are pleased to present our latest findings, which demonstrate that BORA plays a key role in the metastatic capacity of ovarian cancer (OC) cells by triggering a PLK1‐mediated induction of epithelial‐mesenchymal transition (EMT).